502 filings
Page 9 of 26
CORRESP
3n5eh y2ytzbntod7xrh
19 Jul 10
Correspondence with SEC
12:00am
UPLOAD
q0kh7t 4t38
2 Jul 10
Letter from SEC
12:00am
8-K
7x2lvh se9jd8wegv0ip
24 May 10
Departure of Directors or Certain Officers
12:00am
CT ORDER
rvyy p1d1d7
14 May 10
Confidential treatment order
12:00am
8-K
ei176zfi
5 May 10
NPS Pharmaceuticals Reports First Quarter 2010 Financial Results and Continued Progress of Two Phase 3 Registration Programs
12:00am
8-K
k025kngj
21 Apr 10
Other Events
12:00am
8-K
aqe gtixdaqghphku
16 Apr 10
NPS Pharmaceuticals announces proposed public offering of common stock
12:00am
424B5
gitvrhh hyqewm
16 Apr 10
Prospectus supplement for primary offering
12:00am
FWP
7tx15lv4h87t ruwi
15 Apr 10
Free writing prospectus
12:00am
424B5
uehh8do ozd0
15 Apr 10
Prospectus supplement for primary offering
12:00am
ARS
qfg5oe
13 Apr 10
Annual report to shareholders
12:00am
DEFA14A
zhdu3xi7f7st o9epw
8 Apr 10
Additional proxy soliciting materials
12:00am
8-K
h17o 7xpsww6h
11 Mar 10
NPS Pharmaceuticals Reports 2009 Results and 2010 Outlook
12:00am
8-K
gosq32o
2 Mar 10
NPS Pharmaceuticals Receives $38.4 Million for Sale of REGPARA Royalty Rights
12:00am
8-K
ab6b4
22 Jan 10
Other Events
12:00am
8-K
t2s a7eibjb5obbp
9 Dec 09
Other Events
12:00am